Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XNW3009 vs benzbromarone in hyperuricemia with or without gout (Phase II)
CTR20210362Phase 2Completed
- Sponsor
- Sinoway Pharmaceutical
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of xininurad in hyperuricemia, gout, sponsored by Sinoway Pharmaceutical. Started Mar 2021; status: completed.
02
Drugs
xininurad
03
Conditions
hyperuricemiagout
Beyond the preview
Go deeper on CTR20210362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210362.